TITRE (EN) Liquid biopsy for Non-Small Cell Lung Cancer: comparing plasma cell-free DNA/RNA to tissue NGS to assesses turnaround time, patient distress and cost-effectiveness
PROTOCOLE ID QC-LIQBIOP
CLINICAL TRIAL.gov ID n.d.
TYPE(S) DE CANCER Poumon non à petites cellules
PHASE Autres
TYPE D'ÉTUDE
INSTITUTION CUSM
1001 boul. Décarie
VILLE Montréal
INVESTIGATEUR(RICE) PRINCIPAL(E) Scott Owen
COORDONATEUR(RICE) Nicola Raby
nicola.raby@muhc.mcgill.ca
514-934-1934 poste 34095
STATUT  Actif en recrutement
CRITÈRES D'ÉLIGIBILITÉ (EN)
  • Patients with suspected advanced non-squamous Non-Small Cell Lung Cancer (NSCLC), Stage III or IV who are eligible for a diagnostic biopsy procedure.
  • No medical contraindications for diagnostic procedure
  • Provide written informed consent in accordance with institutional guidelines.
CRITÈRES D'EXCLUSION (EN)
  • Past medical history of other cancer within the last 3 years
  • Tissue biopsy is not possible for any reason